Clinical study shows drug has COVID-19 treatment potential 11-May-2021 By Jenni Spinner Interim data reportedly indicates Noxopharm’s Veyonda could be effective in treating cytokine storm, an inflammatory effect associated with moderate cases.
First COVID-19 patient treated in Noxopharm study 13-Oct-2020 By Jenni Spinner The clinical-stage drug development company has kicked off testing the experimental anticancer drug Veyonda on severe patients in a Phase I trial.